SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Eli Lilly
LLY 820.10-0.8%Oct 28 9:30 AM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Moonray1/21/2021 9:46:21 AM
1 Recommendation

Recommended By
Lance Bredvold

   of 636
 
Monoclonal antibody treatment by Eli Lilly found
to cut risk of serious COVID-19, drugmaker reports
Karen Weintraub, USA TODAY, Jan 21, 2021

A drug developed by Eli Lilly and Company dramatically
reduced the risk of developing symptomatic COVID-19
among nursing home residents, the company found.

Of 299 residents, half of whom received a placebo, those
randomized to receive the drug bamlanivimab had up to
an 80% lower risk of contracting COVID-19, according to
a study that has not yet been published.

More at: usatoday.com

o~~~ O
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News